SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Edwards Lifesciences Corp | 52,362,913 | 8.6% | EDGAR |
SC 13G/A | 2024-01-25 | BlackRock Inc. | Edwards Lifesciences Corp | 52,171,889 | 8.6% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Edwards Lifesciences Corp | 51,559,391 | 8.3% | EDGAR |
SC 13G/A | 2023-02-07 | BlackRock Inc. | Edwards Lifesciences Corp | 53,060,508 | 8.6% | EDGAR |
SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | Edwards Lifesciences Corp | 49,076,649 | 7.9% | EDGAR |
SC 13G/A | 2022-02-03 | BlackRock Inc. | Edwards Lifesciences Corp | 57,040,983 | 9.1% | EDGAR |
SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | Edwards Lifesciences Corp | 48,347,685 | 7.8% | EDGAR |
SC 13G/A | 2021-01-29 | BlackRock Inc. | Edwards Lifesciences Corp | 58,596,560 | 9.4% | EDGAR |
SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | Edwards Lifesciences Corp | 16,261,702 | 7.8% | EDGAR |
SC 13G/A | 2020-02-05 | BlackRock Inc. | Edwards Lifesciences Corp | 18,200,799 | 8.7% | EDGAR |
SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | Edwards Lifesciences Corp | 21,856,659 | 10.4% | EDGAR |
SC 13G/A | 2019-02-04 | BlackRock Inc. | Edwards Lifesciences Corp | 16,431,419 | 7.9% | EDGAR |
SC 13G/A | 2018-02-09 | VANGUARD GROUP INC | Edwards Lifesciences Corp | 21,328,999 | 10.1% | EDGAR |
SC 13G/A | 2018-01-29 | BlackRock Inc. | Edwards Lifesciences Corp | 15,410,737 | 7.3% | EDGAR |
SC 13G/A | 2017-12-11 | VANGUARD GROUP INC | Edwards Lifesciences Corp | 21,210,600 | 10.0% | EDGAR |
SC 13G/A | 2017-02-14 | SANDS CAPITAL MANAGEMENT, LLC | Edwards Lifesciences Corp | 8,327,338 | 3.9% | EDGAR |
SC 13G/A | 2017-02-09 | VANGUARD GROUP INC | Edwards Lifesciences Corp | 19,835,943 | 9.3% | EDGAR |
SC 13G/A | 2017-01-24 | BlackRock Inc. | Edwards Lifesciences Corp | 13,913,553 | 6.5% | EDGAR |
SC 13G/A | 2016-02-16 | Capital Research Global Investors | Edwards Lifesciences Corp | 8,561,600 | 4.0% | EDGAR |
SC 13G | 2016-02-16 | SANDS CAPITAL MANAGEMENT, LLC | Edwards Lifesciences Corp | 10,924,382 | 5.1% | EDGAR |